Natasha Hernday

Insider Reports History

Identity
Location
Incline Village, NV
SEC record
Reporting signature
/s/ Maricel Montano, Attorney-in-Fact for Natasha Hernday
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Natasha Hernday:

Form 4 holding Director

XOMA Royalty Corp

Security class
8.625% Series A Cumulative Perpetual Preferred Stock
Shares / value
4,000
Estimated value
Report date
21 May 2026
Price
Ownership
Direct
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Stock Option (Right to buy)
Shares / value
0
Estimated value
Report date
20 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Natasha Hernday

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .